Skip to main content
main-content

01.12.2012 | Research article | Ausgabe 1/2012 Open Access

BMC Health Services Research 1/2012

Designation, diligence and drift: understanding laboratory expenditure increases in British Columbia, 1996/97 to 2005/06

Zeitschrift:
BMC Health Services Research > Ausgabe 1/2012
Autoren:
Saskia N Sivananthan, Sandra Peterson, Ruth Lavergne, Morris L Barer, Kimberlyn M McGrail
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1472-6963-12-472) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

All authors contributed to the interpretation of the data. KM and MB conceived and developed the initial design of the study and acquired the data. SS managed the study, further developing the design, conducted the analysis and interpretation of the data. SP and RL contributed significantly to the analysis and interpretation. SS wrote the first draft and managed subsequent drafts with revisions from all other authors. All authors read and approved the final manuscript.

Abstract

Background

Laboratory testing is one of the fastest growing areas of health services spending in Canada. We examine the extent to which increases in laboratory expenditures might be explained by testing that is consistent with guidelines for the management of chronic conditions, by analyzing fee-for-service physician payment data in British Columbia from 1996/97 and 2005/06.

Method

We used direct standardization to quantify the effect on laboratory expenditures from changes in: fee levels; population growth; population aging; treatment prevalence; expenditure on recommended tests for those conditions; and expenditure on other tests. The chronic conditions selected were those with guidelines containing laboratory recommendations developed by the BC Guidelines and Protocol Advisory Committee: diabetes, hypertension, congestive heart failure, renal failure, liver disease, rheumatoid arthritis, osteoarthritis and dementia.

Result

Laboratory service expenditures increased by $98 million in 2005/06 compared to 1996/97, or 3.6% per year after controlling for population growth and aging. Testing consistent with guideline-recommended care for chronic conditions explained one-third (1.2% per year) of this growth. Changes in treatment prevalence were just as important, contributing 1.5% per year. Hypertension was the most common condition, but renal failure and dementia showed the largest changes in prevalence over time. Changes in other laboratory expenditure including for those without chronic conditions accounted for the remaining 0.9% growth per year.

Conclusion

Increases in treatment prevalence were the largest driver of laboratory cost increases between 1996/97 and 2005/06. There are several possible contributors to increasing treatment prevalence, all of which can be expected to continue to put pressure on health care expenditures.
Zusatzmaterial
Additional file 1: BC Guidelines and Protocol Advisory Committee recommended laboratory tests attributed to each of the eight chronic conditions examined.(DOC 60 KB)
12913_2012_2375_MOESM1_ESM.doc
Authors’ original file for figure 1
12913_2012_2375_MOESM2_ESM.pdf
Authors’ original file for figure 2
12913_2012_2375_MOESM3_ESM.pdf
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

BMC Health Services Research 1/2012 Zur Ausgabe